375 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Q2 Earnings Season Coming Up Roses http://www.zacks.com/stock/news/224205/q2-earnings-season-coming-up-roses?cid=CS-ZC-FT-224205 Jul 20, 2016 - Morgan Stanley, Abbott Labs and Halliburton all beat earnings expectations before the opening bell today.
Medical Stocks to Post Earnings This Week: ABT, BIIB, ALIOF http://www.zacks.com/stock/news/223981/medical-stocks-to-post-earnings-this-week-abt-biib-aliof?cid=CS-ZC-FT-223981 Jul 19, 2016 - Medical is one of the few sectors that are poised to report earnings growth this quarter. While the sector's second-quarter earnings are projected to improve 0.5%, revenues are expected to grow 7.7%.
Alere Updates on 10K Filing, Reports Preliminary Q1 Figures http://www.zacks.com/stock/news/223683/alere-updates-on-10k-filing-reports-preliminary-q1-figures?cid=CS-ZC-FT-223683 Jul 15, 2016 - Alere Inc. (ALR) lowered revenue estimate for the year that ended on Dec 31, 2015 and also offered some Q1 figures.
Why is Alere Inc. (ALR) up Today? http://www.zacks.com/stock/news/223673/why-is-alere-inc-alr-up-today?cid=CS-ZC-FT-223673 Jul 15, 2016 - Alere Inc. (ALR) is up 10.5% in afternoon trading on Friday after analysts saw an increased likelihood that the company's $5.8 billion acquisition by Abbott Laboratories (ABT) would close.
Eli Lilly, Boehringer Collaborate for Metastatic Breast Cancer http://www.zacks.com/stock/news/223479/eli-lilly-boehringer-collaborate-for-metastatic-breast-cancer?cid=CS-ZC-FT-223479 Jul 14, 2016 - Eli Lilly (LLY) inked a clinical trial collaboration with Boehringer for the evaluation of abemaciclib-BI 836845 combination for metastatic breast cancer.
Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical http://www.zacks.com/stock/news/223442/zacks-industry-outlook-highlights-johnson-johnson-smith-nephew-medtronic-abbott-laboratories-and-st-jude-medical?cid=CS-ZC-FT-223442 Jul 14, 2016 - Zacks Industry Outlook Highlights: Johnson & Johnson, Smith & Nephew, Medtronic, Abbott Laboratories and St. Jude Medical
MedTech Tailwinds at a Glance: Which Stocks to Buy? http://www.zacks.com/commentary/85844/medtech-tailwinds-at-a-glance-which-stocks-to-buy?cid=CS-ZC-FT-85844 Jul 13, 2016 - MedTech Tailwinds at a Glance: Which Stocks to Buy?
Pfizer (PFE) Gets FDA Nod for Label Expansion of Prevnar 13 http://www.zacks.com/stock/news/223329/pfizer-pfe-gets-fda-nod-for-label-expansion-of-prevnar-13?cid=CS-ZC-FT-223329 Jul 13, 2016 - Pfizer Inc. (PFE) announced that the FDA has approved a label expansion of vaccine Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S. http://www.zacks.com/stock/news/223158/abbvies-abt-414-gets-rare-pediatric-disease-status-in-us?cid=CS-ZC-FT-223158 Jul 12, 2016 - AbbVie's (ABBV) ABT-414 has been granted Rare Pediatric Disease Designation in the U.S. for the treatment of pediatric patients with EGFR-amplified DIPG.
Abbott Laboratories (ABT) Miles D. White on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3966643-abbott-laboratories-abt-miles-d-white-q1-2016-results-earnings-call-transcript?source=feed_tag_transcripts Apr 20, 2016 - Abbott Laboratories (NYSE:ABT)Q1 2016 Earnings CallApril 20, 2016 9:00 am ETExecutivesScott Leinenweber - Vice President, Investor RelationsMiles D. White - Chairman & Chief Executive OfficerBrian B.

Pages: 1...32333435363738

<<<Page 37